Gene · 5582
Papers1,943
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,943
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Programming With Varying Dietary Fat Content Alters Cardiac Insulin Receptor, Glut4 and FoxO1 Immunoreactivity in Neonatal Rats, Whereas High Fat Programming Alters Cebpa Gene Expression in Neonatal Female Rats. | Front Endocrinol (Lausanne) | 2021 | 35069436 | PubTator, text mining | PubMed |
| DNA Microarray-Based Global Gene Expression Profiling in Human Amniotic Epithelial Cells Predicts the Potential of Microalgae-Derived Squalene for the Nervous System and Metabolic Health. | Biomedicines | 2021 | 35052729 | PubTator, text mining | PubMed |
| The Important Role of Ion Transport System in Cervical Cancer. | Int J Mol Sci | 2021 | 35008759 | PubTator, text mining | PubMed |
| mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses. | Sci Rep | 2021 | 34952911 | PubTator, text mining | PubMed |
| The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer. | Front Cell Dev Biol | 2021 | 34938735 | PubTator, text mining | PubMed |
| SYT7 acts as an oncogene and a potential therapeutic target and was regulated by ΔNp63α in HNSCC. | Cancer Cell Int | 2021 | 34930262 | PubTator, text mining | PubMed |
| V-ATPase V0a1 promotes Weibel-Palade body biogenesis through the regulation of membrane fission. | Elife | 2021 | 34904569 | PubTator, text mining | PubMed |
| Nanotechnology for Pain Management: Current and Future Therapeutic Interventions. | Nano Today | 2021 | 34899962 | PubTator, text mining | PubMed |
| T cell receptor (TCR) signaling in health and disease. | Signal Transduct Target Ther | 2021 | 34897277 | PubTator, text mining | PubMed |
| Phosphocatalytic Kinome Activity Profiling of Apoptotic and Ferroptotic Agents in Multiple Myeloma Cells. | Int J Mol Sci | 2021 | 34884535 | PubTator, text mining | PubMed |
| Supraphysiological Role of Melatonin Over Vascular Dysfunction of Pregnancy, a New Therapeutic Agent? | Front Physiol | 2021 | 34867473 | PubTator, text mining | PubMed |
| Case Report: Prominent Brainstem Involvement in Two Patients With Anti-CASPR2 Antibody-Associated Autoimmune Encephalitis. | Front Immunol | 2021 | 34858431 | PubTator, text mining | PubMed |
| Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials. | Pharmaceutics | 2021 | 34834162 | PubTator, text mining | PubMed |
| Opioid Analgesia and Opioid-Induced Adverse Effects: A Review. | Pharmaceuticals (Basel) | 2021 | 34832873 | PubTator, text mining | PubMed |
| Aβ1-40-Induced Platelet Adhesion Is Ameliorated by Rosmarinic Acid through Inhibition of NADPH Oxidase/PKC-δ/Integrin αIIbβ3 Signaling. | Antioxidants (Basel) | 2021 | 34829541 | PubTator, text mining | PubMed |
| Reversible phosphorylation of cyclin T1 promotes assembly and stability of P-TEFb. | Elife | 2021 | 34821217 | PubTator, text mining | PubMed |
| Loss of zinc-finger protein 212 leads to Purkinje cell death and locomotive abnormalities with phospholipase D3 downregulation. | Sci Rep | 2021 | 34815492 | PubTator, text mining | PubMed |
| Multidimensional Mutational Profiling of the Indian HNSCC Sub-Population Provides IRAK1, a Novel Driver Gene and Potential Druggable Target. | Front Oncol | 2021 | 34796107 | PubTator, text mining | PubMed |
| Feasibility and significance of stimulating interscapular muscles using transcutaneous functional electrical stimulation in able-bodied individuals. | J Spinal Cord Med | 2021 | 34779732 | PubTator, text mining | PubMed |
| Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis. | Int J Mol Sci | 2021 | 34768988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5582/papers?page=19